Free Republic

A Japanese conglomerate has found that the anti-parasitic drug ivermectin is effective and safe for the treatment of the coronavirus Omicron variant, according to a phase III clinical trial.Kowa Co. Ltd., a conglomerate with interests in trading, hospitality, and electronics, along with health and medical applications, issued a press release (pdf) on Jan. 31 stating that ivermectin has been found to be effective against Omicron.Kowa representatives didn’t respond to a request for comment by press time.The company, working with Kitasato University based in Tokyo, said that ivermectin has the “same antiviral effect” on all “mutant strains,” including Alpha, Delta, and...

TOKYO, Jan 31 (Reuters) - Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against Omicron and other variants of coronavirus in joint non-clinical research. Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo. Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing ...

TOKYO, Jan 31 (Reuters) - Japanese trading and pharmaceutical company Kowa Co Ltd (7807.T) said on Monday anti-parasite drug ivermectin has an "antiviral effect" against Omicron and other variants of COVID-19 as Phase III clinical trials continue.